Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort-Reference-Cited by-同舟云学术

Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort

Published:2022-10 Issue: Volume:123 Page:104-111
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Navaratnam Annalan M D^ORCID,Shrotri Madhumita^ORCID,Nguyen Vincent,Braithwaite Isobel,Beale Sarah^ORCID,Byrne Thomas E,Fong Wing Lam Erica,Fragaszy Ellen,Geismar Cyril,Hoskins Susan^ORCID,Kovar Jana,Patel Parth^ORCID,Yavlinsky Alexei,Aryee Anna^ORCID,Rodger Alison,Hayward Andrew C,Aldridge Robert W^ORCID,Michie Susan,Hardelid Pia,Wijlaars Linda,Nastouli Eleni,Spyer Moira,Killingley Ben,Cox Ingemar,Lampos Vasileios,McKendry Rachel A,Cheng Tao,Liu Yunzhe,Gibbs Jo,Gilson Richard,Johnson Anne M

Funder

Wellcome Trust

Medical Research Council

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison;Ainsworth;Lancet Infect Dis,2020

2. A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States;Alfego;EClinicalmedicine,2021

3. SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19;Ali;New Microbes New Infect,2021

4. A rapid review and meta-analysis of the asymptomatic proportion of PCR-confirmed SARS-CoV-2 infections in community settings;Beale;Wellcome Open Res,2020

5. Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination;Bochnia-Bueno;Diagnostic Microbiology and Infectious Disease,2022

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults;BMC Infectious Diseases;2024-08-20

2. Differences in SARS-CoV-2 antibodies depending on age, blood group, and sex in a Swedish blood donor cohort;Scandinavian Journal of Clinical and Laboratory Investigation;2024-06-21

3. Anti-Nucleocapsid and Anti-Spike Antibody Trajectories in People with Post-Covid Condition versus Acute-Only Infections: Results from the Virus Watch Prospective Cohort Study;2024-06-19

4. SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response;Influenza and Other Respiratory Viruses;2024-06

5. SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general population;Vaccine: X;2024-06